(Q45013063)

8 December 2017

title

Adverse effects of atypical antipsychotic agents and their effects on quality of life (English)

1 reference

8 December 2017

1 reference

Beth M Dubisar

1

1 reference

8 December 2017

Steven C Stoner

2

1 reference

8 December 2017

James Reynolds

3

1 reference

8 December 2017

Rintu Khan

4

1 reference

8 December 2017

Leonard Ramlatchman

5

1 reference

8 December 2017

language of work or name

English

0 references

publication date

1 July 2004

1 reference

8 December 2017

1 reference

8 December 2017

volume

24

1 reference

8 December 2017

issue

7

1 reference

8 December 2017

page(s)

843-847

1 reference

The Texas Medication Algorithm Project: development and implementation of the schizophrenia algorithm.

8 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.9.843.36098

Safety and tolerability: how do newer generation "atypical" antipsychotics compare?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.9.843.36098

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.9.843.36098

Diabetes mellitus and other metabolic disturbances induced by atypical antipsychotic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.9.843.36098

Novel antipsychotics and severe hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.9.843.36098

Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.9.843.36098

Refining quality of life: validating a multidimensional factor measure in the severe mentally ill.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.9.843.36098

Subjective well-being and quality of life under atypical antipsychotic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.9.843.36098

Sertraline in the treatment of panic disorder: a double-blind multicenter trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.9.843.36098

Antihypertensive treatment of patients with diabetes and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.9.843.36098

Weight gain and serum leptin levels in patients on lithium treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.9.843.36098

10.1592/PHCO.24.9.843.36098

21 January 2018

Identifiers

DOI

1 reference

8 December 2017

1 reference